Lotus Eye Hospital & Institute (BOM:532998) 3-Year EBITDA Growth Rate : 29.70% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Lotus Eye Hospital & Institute 3-Year EBITDA Growth Rate?

Lotus Eye Hospital & Institute's EBITDA per Share for the three months ended in Dec. 2023 was ₹0.93.

During the past 12 months, Lotus Eye Hospital & Institute's average EBITDA Per Share Growth Rate was -0.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 29.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 7.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Lotus Eye Hospital & Institute was 29.70% per year. The lowest was -27.20% per year. And the median was 2.30% per year.

Competitive Comparison of Lotus Eye Hospital & Institute's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lotus Eye Hospital & Institute's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's 3-Year EBITDA Growth Rate falls into.

Lotus Eye Hospital & Institute 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Lotus Eye Hospital & Institute (BOM:532998) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Lotus Eye Hospital & Institute 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Lotus Eye Hospital & Institute's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Lotus Eye Hospital & Institute (BOM:532998) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lotus Eye Hospital & Institute Ltd (BOM:532998) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

LOTUSEYE:India

Address

SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014

Website

https://www.lotuseye.org

Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, and contact lens, and optical, of which the majority of the revenue is derived from providing segmmedical services.

Lotus Eye Hospital & Institute (BOM:532998) Headlines

No Headlines